SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-16-074623
Filing Date
2016-08-03
Accepted
2016-08-03 16:16:29
Documents
47
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 EDGE THERAPEUTICS, INC 10-Q 6-30-2016 form10q.htm 10-Q 519183
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 11859
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 11744
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4687
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4636
  Complete submission text file 0001140361-16-074623.txt   3172448

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT edge-20160630.xml EX-101.INS 470205
7 XBRL TAXONOMY EXTENSION SCHEMA edge-20160630.xsd EX-101.SCH 28986
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20160630_cal.xml EX-101.CAL 38639
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20160630_def.xml EX-101.DEF 148554
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20160630_lab.xml EX-101.LAB 492621
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20160630_pre.xml EX-101.PRE 261688
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 161804058
SIC: 2834 Pharmaceutical Preparations